These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6151431)

  • 21. [Multiple endocrine neoplasms (MEN I): experience with 15 cases].
    Herrera Pombo JL; Cordido F; Rapado A; Horcajada C; Rovira A
    Med Clin (Barc); 1987 May; 88(19):754-9. PubMed ID: 2886709
    [No Abstract]   [Full Text] [Related]  

  • 22. [Endocrine disorders in "empty" sella turcica].
    Mizetskaia EA; Snigireva RIa
    Zh Vopr Neirokhir Im N N Burdenko; 1984; (6):12-7. PubMed ID: 6528785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W; Ikeda H; Yoshimoto T
    Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenoma.
    Tinnel BA; Henderson MA; Witt TC; Fakiris AJ; Worth RM; Des Rosiers PM; Edmondson JW; Timmerman RD; Lo SS
    Stereotact Funct Neurosurg; 2008; 86(5):292-6. PubMed ID: 18758206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender-related differences in prolactin secretion in pituitary prolactinomas.
    Nishioka H; Haraoka J; Akada K; Azuma S
    Neuroradiology; 2002 May; 44(5):407-10. PubMed ID: 12012125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood-cerebrospinal fluid barrier for prolactin in empty sella syndrome.
    Coculescu M; Temeli E; Oprescu M; Simionescu N
    Endocrinologie; 1981; 19(3):199-206. PubMed ID: 7291947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred.
    Burgess JR; Shepherd JJ; Parameswaran V; Hoffman L; Greenaway TM
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2642-6. PubMed ID: 8675591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactinomas in familial multiple endocrine neoplasia syndrome type I. Relationship to HLA and carcinoid tumors.
    Farid NR; Buehler S; Russell NA; Maroun FB; Allerdice P; Smyth HS
    Am J Med; 1980 Dec; 69(6):874-80. PubMed ID: 6108714
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prolactin adenoma and Wermer's syndrome. A 10-year follow-up of a case with two parathyroid tumors, as adrenal adenoma, and a malignant pancreatic tumor (author's transl)].
    Thomas M; Dry J
    Ann Med Interne (Paris); 1979 Dec; 130(12):621-4. PubMed ID: 44160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland.
    Petty EM; Green JS; Marx SJ; Taggart RT; Farid N; Bale AE
    Am J Hum Genet; 1994 Jun; 54(6):1060-6. PubMed ID: 7911003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Beneficial effect of Parlodel in a case of simultaneous prolactinoma and empty sella syndrome].
    Oó M; Deák G; Genszky K; Pintér E; Rábai K; Szalóczy P; Szilágyi G; Szücs K
    Orv Hetil; 1983 Dec; 124(51):3121-4. PubMed ID: 6657258
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of 6 pituitary hormones in the cerebrospinal fluid. Control subjects, prolactin adenomas, empty sella syndrome and hypothalamic disorders (author's transl)].
    Turpin G; Heshmati HM; Roger M; Cesselin E; Lagoguey M; Baulieu JL; de Gennes JL
    Ann Endocrinol (Paris); 1979; 40(4):425-6. PubMed ID: 518022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pituitary adenoma, hyperparathyroidism and hyperthyrosis. Report of a case with multiple endocrine adenomatosis with consanguinity of the patient's parents].
    Maurer W; Walser A; Gloor F
    Schweiz Med Wochenschr; 1966 Apr; 96(16):536-42. PubMed ID: 4383335
    [No Abstract]   [Full Text] [Related]  

  • 34. [MEN I with involvement of 4 endocrine organs].
    Tébar Massó FJ; Ascaso Gimilio J; Ramírez Muñoz L; Lozano Teruel MG
    Med Clin (Barc); 1985 Jan; 84(2):80-1. PubMed ID: 2857801
    [No Abstract]   [Full Text] [Related]  

  • 35. Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists.
    Genazzani AR; De Leo V; Murru S; Cocchi D; Camanni F; Müller EE
    J Clin Endocrinol Metab; 1982 Feb; 54(2):429-35. PubMed ID: 7054227
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolactinomas in a large kindred with multiple endocrine neoplasia type 1: clinical features and inheritance pattern.
    Burgess JR; Shepherd JJ; Parameswaran V; Hoffman L; Greenaway TM
    J Clin Endocrinol Metab; 1996 May; 81(5):1841-5. PubMed ID: 8626844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diurnal variation of prolactin secretion differentiates pituitary tumors from the primary empty sella syndrome.
    Malarkey WB; Goodenow TJ; Lanese RR
    Am J Med; 1980 Dec; 69(6):886-90. PubMed ID: 7192490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kinetics of prolactinemia after withdrawal of dopamine perfusion and during the administration of domperidone. Normal and hyperprolactinemic subjects (prolactinomas and suprahypophyseal lesions)].
    Bercovici JP; Khoury S; Tater D; Besson G; Caroff J
    Biomed Pharmacother; 1983; 37(5):222-7. PubMed ID: 6661508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct dopaminergic personality patterns in patients with prolactinomas: a comparison with nonfunctioning pituitary adenoma patients and age- and gender-matched controls.
    Athanasoulia AP; Ising M; Pfister H; Mantzoros CS; Stalla GK; Sievers C
    Neuroendocrinology; 2012; 96(3):204-11. PubMed ID: 22343218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for multiple endocrine neoplasia syndrome (type 1) in patients with primary hyperparathyroidism.
    Muhr C; Ljunghall S; Akerstrom G; Palmér M; Bergström K; Enoksson P; Lundqvist G; Wide L
    Clin Endocrinol (Oxf); 1984 Feb; 20(2):153-62. PubMed ID: 6143630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.